Macdermid agrees sale

Gibson, Jane
April 2007
ICIS Chemical Business;4/23/2007, Vol. 2 Issue 63, p15
Trade Publication
The article reports that Macdermid shareholders have agreed to a takeover by its chief executive officer (CEO), Daniel Leever, and two investment funds in a $1.3bn (€960m) buyout. Shares will be sold for $35 under the agreement. MacDermid is a maker of specialty chemical processes for the metal and plastic finishing, electronics and graphic arts sectors.


Related Articles

  • Platform acquires MacDermid for $1.8 billion, plans more deals. WESTERVELT, ROBERT // Chemical Week;10/21/2013, Vol. 175 Issue 27, p9 

    The article reports on the October 2013 purchase of specialty chemical company MacDermid by investment firm Platform Acquisition Holdings for 1.8 million dollars. The new business will transition to a publicly traded company named Platform Specialty Products. Other topics include Platform...

  • MacDermid charts expansion to hike profits. McConville, Daniel J. // Chemical Week;6/1/1994, Vol. 154 Issue 21, p37 

    Reports on the expansion plans of MacDermid Inc. to improve its earnings. Acquisition of Allied-Kelite; Chemical products manufactured by MacDermid; Sales of electronic chemicals used in circuit boards; Sensitivity of the company to the ebb and flow of business cycles; Financial performance of...

  • CW75 stock performance.  // Chemical Week;9/6/2006, Vol. 168 Issue 30, p41 

    The article presents the CW75 stock performance of chemical companies as of September 2006. The CW75 Index fell 1% for the week. MacDermid topped the leaders list on news that CEO Daniel H. Leever have offered to purchases all of MacDermid's outstanding common stock for $32.50 per share. Basic...

  • MacDermid Mixing Up New $925 Million Debt Potion. M. S. // High Yield Report;2/12/2007, Vol. 18 Issue 6, p1 

    The article reports on the buyout agreement between MacDermid Inc. and chairman and chief executive officer Daniel Leever and private equity firms Court Square Capital Partners and Weston Presidio Capital in the specialty chemical industry in the U.S. The agreement came after MacDermid entered...

  • MacDermid Deal Could Start Trend Toward Privatization. Walsh, Kerri // Chemical Week;9/20/2006, Vol. 168 Issue 31, p15 

    This article reports that the proposed acquisition of MacDermid by Chairman and CEO Daniel Leever and Court Square Capital Partners could mark the start of a privatization trend, according to Lawrence Alexander, analyst at Jefferies. MacDermid's market cap is about $1 billion. Several chemical...

  • MacDermid Squeeze-out Offer May Be Slightly Low Ball. G. C. // Mergers & Acquisitions Report;10/2/2006, Vol. 19 Issue 37, p4 

    The article reports on the offer of Daniel Leever, chairman and chief executive officer of MacDermid Inc. and private equity group Court Square Capital Partners to acquire the company. MacDermid hired Merrill Lynch as its financial advisor to review the bid. The price per share offered by Leever...

  • Finger on the LBO trigger. Chang, Joseph // ICIS Chemical Business Americas;9/18/2006, Vol. 270 Issue 10, p12 

    The article reports on the bid made by MacDermid CEO Daniel Leever and Court Street Capital Partners to take the company private. Jefferies & Co. analyst Laurence Alexander believes that bid could drive more leveraged buyouts in the small-capitalization chemical sector. Leever is offering $32.50...

  • MacDermid CEO Bids to Take Company Private. Westervelt, Robert // Chemical Week;9/6/2006, Vol. 168 Issue 30, p6 

    The article discusses the offer of MacDermid chairman and CEO Daniel Leever and Court Square Capital Partners to acquire MacDermid for $1 billion. The bid represents a 16% premium to MacDermid's closing price. Leever says that he expects that the company's senior management team will participate...

  • MacDermid board in $1bn buy-out bid. Robinson, Simon // ICIS Chemical Business;9/11/2006, Vol. 1 Issue 34, p17 

    This article reports on the launch of a management buy-out attempt at MacDermid. Daniel Leever, chairman and CEO of MacDermid, and Joseph Silvestri, another director, made the offer with investment firm Court Square Capital Partners offering to buy shares for $32.50/share. The bid is at a 20%...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics